title: Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature.
abstract: Cancer survivorship represents a new challenge in the third Millennium. In Europe the number of cancer survivors was estimated to be 17,8 million in 2008 and this number is growing. Recent improvements in cancer survival are largely due to earlier diagnosis and advancements in treatment. Despite having favorable effects on cancer survival, radiation therapy, surgery treatment and combination chemotherapy regimens can also cause long-term organ damage and functional disabilities. In this paper we review the most important aspects of long-term toxicities in otolaryngology cancer survivors patients.
authors.affiliation: Department of Medical Oncology, CRO Aviano National Cancer Institute, Aviano, Italy. rostai@libero.it.
authors.forename: R
authors.initials: R
authors.lastname: Taibi
authors.forename: A
authors.initials: A
authors.lastname: Lleshi
authors.forename: L
authors.initials: L
authors.lastname: Barzan
authors.forename: F
authors.initials: F
authors.lastname: Fiorica
authors.forename: M
authors.initials: M
authors.lastname: Leghissa
authors.forename: E
authors.initials: E
authors.lastname: Vaccher
authors.forename: P
authors.initials: P
authors.lastname: De Paoli
authors.forename: G
authors.initials: G
authors.lastname: Franchin
authors.forename: M
authors.initials: M
authors.lastname: Berretta
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D059248:Chemoradiotherapy / Q000009:adverse effects; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D011183:Postoperative Complications; D017741:Survivors / Q000706:statistics & numerical data*
chemical_list: D000970:Antineoplastic Agents